The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) Post author:Sam Post published:September 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Booming C4 Therapeutics to Move Out of Pricey Kendall Square Next Year July 10, 2017 Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017 Pfizer Makes a $545 Million Deal With Another Bay Area Biotech, Sangamo May 10, 2017
Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017